Downregulation of miR-1247-3p inhibited apoptosis and reduced chemosensitivity in cells. by Dequan Wang (6007007)

Subjects:

Overexpression of miR-1247-3p promoted apoptosis and inhibited resistance in drug-resistant cells. by Dequan Wang (6007007)

Subjects:

Flow of premises through the study. by Eleni Mantzari (6991172)

Subjects:

The Laboratory Animal Flow Diagram. by Xueqin lu (22250795)

“…Meanwhile, Kylo-0603 demonstrated a marked improvement in histological parameters, decreasing steatosis by up to 1.3 points (P < 0.001), inflammation by 1.8 points (P < 0.0001), and ballooning by 0.8 points (P < 0.01). …”

Flow chart. by Raphaele Houlbracq (20558509)

Flow chart from invitation to analyses. *For administrative reasons HbA1c was not available for a small subset of the population. by Martin Gillies Banke Rasmussen (10227291)

Cinacalcet administered early in the inactive phase markedly decrease parathyroid Ki-67 index. by Søren Egstrand (10906087)

The parameters of gas exchange markedly decreased in maize <i>zmstomagen1/2</i> mutant compared with in wild type (WT). by Juan-Juan Xu (18590868)

Flow diagram illustrating the sequence of procedures executed during one time step defined as tick, each of which represents one week. by Alexandra M. Campbell (3284094)

Flow chart of participants selection. by Linjia Duan (13276989)

PRISMA flow chart of the study selection process. by Mairena Sánchez-López (684092)

A flow diagram of the study entry. by Sakiko Fukui (387048)

Estimation procedure flow-chart. by Stephan Dietrich (6979985)

Study flow chart. by Benjamin R. Lewis (22279166)

Experimental flow chart. by Dong Feng (5375471)

Metabolites with decreasing levels during the development. by Martin Sládek (130663)

Study flow chart. by Iben Axén (3430445)

<i>RTTN</i>-mutated organoids exhibit decreased proliferation and increased cell death at early stages. by Justine Guguin (9088672)

The level of miRNA 221 in the myocardium of MIRI mice was decreased. by Hongyu Li (1332669)

Largest changes in influenza vaccine rates, Pre- vs. Post-COVID-19. by Tyler B. Nofzinger (21560244)

Subjects: